https://www.eurekalert.org/news-releases/989642
Sacubitril/valsartan leads to greater reduction in plasma NT-proBNP levels compared to valsartan alone after stabilisation for worsening heart failure in patients with an ejection fraction (EF) above 40%, according to late breaking science presented today at …
Create an account or login to join the discussion